Literature DB >> 2310377

Purification and characterization of heparin-binding growth factors from porcine uterus.

D R Brigstock1, R B Heap, P J Barker, K D Brown.   

Abstract

Heparin-binding growth factors present in pig uterine tissue were purified by approx. 50,000-fold using a combination of ammonium sulphate precipitation, ion-exchange chromatography and heparin-affinity chromatography. Purification of the uterus-derived growth factors (UDGFs) was monitored by the stimulation of [3H]thymidine incorporation into Swiss 3T3 cells and by a radioreceptor assay using 125I-labelled epidermal growth factor (EGF) as the ligand. The latter was shown to be a novel, rapid and reliable assay for heparin-binding growth factors which utilizes their trans-modulation of EGF receptor affinity. UDGFs exhibit strong affinity for immobilized heparin and two forms, named alpha UDGF and beta UDGF, were distinguished by salt gradient elution from heparin-agarose affinity columns. beta UDGF activity was eluted from heparin-agarose between 1.5 M- and 1.8 M-NaCl, and was correlated with the elution of a protein doublet of 17.2 kDa and 17.7 kDa. Immunoblotting of heparin-purified beta UDGF indicated that the beta UDGF doublet is immunologically related to the 146-amino-acid form of bovine basic fibroblast growth factor (bFGF), and that the 17.2 kDa component is an N-terminally truncated form of the 17.7 kDa component. After purification by C4 reversed-phase h.p.l.c., this doublet was biologically active and greater than 95% pure as assessed by silver-stained SDS/PAGE. Amino acid composition and sequence analysis confirmed that these beta UDGF polypeptides were microheterogeneous forms of bFGF. Fractions containing alpha UDGF activity were eluted from heparin-agarose in 1.3 M-NaCl. These fractions contained a 16.5 kDa protein which co-migrated on SDS/polyacrylamide gels with recombinant human acidic FGF (aFGF) and which which cross-reacted with an antiserum raised against aFGF. The identification of heparin-binding growth factors in porcine uterus at the time of implantation raises the possibility that they function in the reproductive tract during early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310377      PMCID: PMC1131124          DOI: 10.1042/bj2660273

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  Identification and purification of truncated insulin-like growth factor I from porcine uterus. Evidence for high biological potency.

Authors:  M Ogasawara; K P Karey; H Marquardt; D A Sirbasku
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

4.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

5.  A unifying hypothesis for the control of blastocyst growth based on observations of the pig.

Authors:  A P Flint
Journal:  J Reprod Fertil Suppl       Date:  1981

6.  Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.

Authors:  M K Collins; J W Sinnett-Smith; E Rozengurt
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

7.  Blastocyst-endometrial interactions and protein synthesis during pre-implantation development in the pig studied in vitro.

Authors:  C Rice; N Ackland; R B Heap
Journal:  Placenta       Date:  1981 Apr-Jun       Impact factor: 3.481

8.  Purification and properties of a mammary-uterine-pituitary tumor cell growth factor from pregnant sheep uterus.

Authors:  T Ikeda; D A Sirbasku
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

9.  Inhibition of epidermal growth factor binding to Swiss 3T3 cells by human platelet release-products.

Authors:  K D Brown; D M Blakeley; M MacDonald
Journal:  Biosci Rep       Date:  1983-07       Impact factor: 3.840

10.  Inhibition of the binding of 125I-labelled epidermal growth factor to mouse cells by a mitogen in goat mammary secretions.

Authors:  K D Brown; D M Blakeley
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more
  1 in total

1.  Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

Authors:  A Sourla; M Koutsilieris
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.